Private raises · SEC Form D
GT Biopharma, Inc.: $8 million Raised, SEC Form D Filings
Company · Biotechnology · CA · SEC CIK 109657 · Company page
Form D notices
A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.
| Filed | Type | Offering | Sold | Industry | |
|---|---|---|---|---|---|
| 29 Sept 2026 | New notice | $39 million | $8 million | Biotechnology | Form D |
Questions and answers
- How much has GT Biopharma, Inc. raised?
- GT Biopharma, Inc. reported $8 million sold in its largest Form D notice on file; its latest notice was filed on 29 September 2026. Form D amounts are what the issuer reported to the SEC.
- What is GT Biopharma, Inc.?
- GT Biopharma, Inc. is a company in biotechnology, based in San Francisco, California, according to its SEC Form D filings.
- How many Form D notices has GT Biopharma, Inc. filed?
- 1 notice between 29 September 2026 and 29 September 2026 in Tamarly's record, which starts on 1 October 2025.
Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "GT Biopharma, Inc.: SEC Form D filings", https://app.tamarly.ai/raisers/109657, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.